# Proxisense

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/proxisense

- Industry: Industrial Machinery
- Headquarters: Oxford, UK
- Website: www.proxisense.com
- Total disclosed funding: $0.5M
- Latest round: Seed (Oct 20, 2016)
- Investors on record: 3

## About

Proxisense Limited develops advanced sensor technologies to enhance process monitoring and control across various manufacturing sectors, including pharmaceuticals and aviation.Founded in 2014 and headquartered in Oxford, UK, Proxisense Limited specializes in sensor technologies for process analytical applications. The company was founded by Jonathan Sullivan, Kam Chana, Mark Papworth, and Paul Vickery. Proxisense has successfully raised GBP 1.07 mn in its latest funding round from Parkwalk Advisors on July 25, 2018, bringing the total amount raised to GBP 1.07 mn and currently values the company at GBP 5.37 mn post-money.Proxisense focuses on developing advanced sensor technologies that enhance process monitoring and control across various manufacturing sectors. The company's main products are smart sensors that leverage Process Analytical Technology (PAT), initially targeting the primary pharmaceutical manufacturing market while also applicable to food, fast-moving consumer goods (FMCG), oil, and environmental monitoring industries. Proxisense's core offerings include highly rugged probes designed for engine air and oil condition monitoring, which provide continuous sensing capabilities for applications such as coolant quality monitoring, oil contamination quantification, and high-frequency temperature and pressure measurement. The company collaborates with partners in both civilian and military aviation, validating its sensors for next-generation turbofan jet applications. Proxisense’s medical diagnostics division has developed a novel sensor for assessing skin lesions, currently undergoing in vivo evaluation as part of a major NHS clinical trial, aimed at creating a rapid screening tool for GP clinics.Proxisense generates revenue through partnerships and collaborations that leverage its innovative sensor technologies. The company's business model is primarily B2B, engaging with manufacturers in various sectors, including pharmaceuticals and aviation, to provide tailored sensor solutions that meet specific industry needs. Transactions typically involve direct sales agreements where clients procure sensor products, which are integral to their manufacturing processes. Additionally, Proxisense may engage in strategic partnerships with organizations involved in research and development, particularly in the medical field, to facilitate clinical trials and product enhancements. Specific information regarding pricing structures or flagship products is not disclosed.The GBP 1.07 mn raised in July 2018 will support Proxisense's initiatives in developing new sensor products and expanding its market reach. The company aims to penetrate additional sectors within manufacturing and healthcare, with a focus on launching innovative solutions by 2020. Proxisense plans to utilize this funding to enhance its research and development capabilities, which will facilitate the introduction of new technologies and promote growth in both domestic and international markets.

## Funding rounds

- Seed, Oct 20, 2016, $0.5M — Future Planet Capital Regional, Parkwalk Advisors, IMechE: Institution of Mechanical Engineers

## Investors

- Future Planet Capital Regional (https://capitalatlas.ai/funds/future-planet-capital-regional) — Seed
- Parkwalk Advisors (https://capitalatlas.ai/funds/parkwalk-advisors) — Seed
- IMechE: Institution of Mechanical Engineers — Seed